10-Q · July 24, 2026
HCSG delivered Q2 revenue of $470.808 million, up 2.7% year over year and 1.7% sequentially, while diluted EPS of $0.32 reversed a $0.44 loss in the prior-year quarter. Gross margin rose to 15.9% and operating margin to…
Earnings analysis · 10-Q
HCSG earnings analysis
Filed October 23, 2026 · Our reading of the company's report
The latest report
HCSG delivered third-quarter revenue of $479.604 million and diluted EPS of $0.36, with EPS materially above the $0.23 consensus estimate while revenue was essentially in line with expectations. Liquidity remained…
Read full summary
HCSG delivered third-quarter revenue of $479.604 million and diluted EPS of $0.36, with EPS materially above the $0.23 consensus estimate while revenue was essentially in line with expectations. Liquidity remained substantial at $204.3 million, and the company repurchased 554,040 shares for $12.567 million. The outlook improved, with fourth-quarter revenue guidance of $535 million to $545 million and the 2027 revenue-growth outlook raised from mid-single-digits to low double-digits, but macroeconomic cost inflation and litigation uncertainty remain headwinds.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.36
What stood out
-
EPS beat despite in-line revenue
Third-quarter revenue was $479.604 million and diluted EPS was $0.36, versus consensus EPS of $0.23; revenue was approximately $1.0 million below the $480.6 million estimate.
-
$204.3M of liquid resources
The company held $204.3 million in cash, cash equivalents, restricted cash equivalents, marketable securities and restricted marketable securities at September 30, 2026.
-
Continued share repurchases
The company repurchased 554,040 shares during the quarter for an aggregate purchase price of $12.567 million, with 7.702 million shares remaining authorized under the 2026 Repurchase Plan.
-
Internal controls remain effective
Management concluded that disclosure controls and procedures and internal control over financial reporting were effective as of September 30, 2026, with no changes that materially affected, or were reasonably likely to materially affect, internal controls during the quarter.
What to watch
-
Geopolitical cost inflation exposure
The newly disclosed macroeconomic risk identifies geopolitical instability and related fuel, energy and commodity-cost volatility as potential pressures on wages, food, supplies, margins and cash flows. The company had $204.3 million of cash, restricted cash, marketable securities and restricted marketable securities at September 30, 2026, but states that the impact of these developments could be material.
-
Unquantified litigation exposure
The company cannot reasonably estimate possible losses or determine whether an unfavorable outcome is probable, reasonably possible or remote for certain pending litigation claims. Although management does not expect pending proceedings to have a material adverse effect on consolidated financial condition or liquidity, outcomes could become material to a particular period.
-
Capital allocation flexibility
Share repurchases reduce available liquidity and capital flexibility: the company spent $12.567 million to repurchase 554,040 shares in the quarter, while 7.702 million shares remained authorized under the 2026 Repurchase Plan.
Management's outlook
The company provided fourth-quarter revenue guidance of $535 million to $545 million and raised its 2027 revenue-growth outlook from mid-single-digits to low double-digits. No numeric EPS guidance was provided.
Earlier filings 4
10-Q · April 24, 2026
Healthcare Services Group beat Q1 estimates with revenue of $462,766,000 (up 3.4% YoY) and diluted EPS of $0.37, driven by EVS strength and margin improvement. Gross margin expanded as costs of services fell to 83.6% of…
10-K · February 13, 2026
HCSG reports scale in the long-term care outsourcing market with consolidated 2025 revenue of $1,837.2 million driven by Dietary ($1,012.5M, 55.1%) and Environmental Services ($824.7M, 44.9%). Credit stress increased…
10-K · February 14, 2025
Healthcare Services Group (HCSG) presents a scale-oriented, outsourcing strategy focused on long‑term care housekeeping and dietary services, servicing ~2,600 facilities and positioning itself as the largest provider in…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.